Skip to main content

Advertisement

SpringerLink
Log in

MRSA and diabetic foot wounds: Contaminating or infecting organisms?

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Although infection is a well-recognized barrier to healing, evidence has emerged that wound colonization with methicillin-resistant Staphylococcus aureus (MRSA) has the same effect, which has been quantified as increasing the time to healing twofold. MRSA is a concern for those with diabetic foot ulcers based on evidence of impaired healing when it is present in the wound. However, many studies have found the bacterial content of diabetic foot ulcers to be polymicrobial, which necessitates MRSA being placed in this environmental context. Multiple variables contribute to the development of infection, including the host response, tissue perfusion, ulcer depth, ulcer location, and an adequate source of nutrition. In view of these factors, it is difficult to attribute infection to one bacterial species.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. International Diabetes Federation: Diabetes prevalence. Available at http://www.idf.org/home/index.cfm?node=264. Accessed September 2009.

  2. Pecoraro RE, Reiber GE, Burgess EM: Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990, 13:513–521.

    Article  CAS  PubMed  Google Scholar 

  3. Lavery LA, Armstrong DG, Wunderlich RP, et al.: Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and Non-Hispanic Whites from a diabetes disease management cohort. Diabetes Care 2003, 26:1435–1438.

    Article  PubMed  Google Scholar 

  4. Boyko EJ, Lipsky BA: Infection and diabetes mellitus. In Diabetes in America. Bethesda, MD: National Institutes of Health; 1995:485–496.

    Google Scholar 

  5. Citron DM, Goldstein EJ, Merriam CV, et al.: Bacteriology of moderate to severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007, 45:2819–2828.

    Article  PubMed  Google Scholar 

  6. Gadepalli R, Dhawan B, Sreenivas V: A clinic-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006, 8:1727–1732.

    Article  Google Scholar 

  7. Diekema DJ, Pfaller MA, Schmitz FJ, et al.: Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific Region for the Sentry Antimicrobial Surveillance Programme 1997-1999. Clin Infect Dis 2001, 32(Suppl 2):114–132.

    Article  Google Scholar 

  8. Eurosurveillance: European Antimicrobial Resistance Surveillance System: Annual Report, 2001. Available at http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=1899. Accessed September 2009.

  9. Jones ME, Karlowsky JA, Draghi DC, et al.: Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents 2003, 22:406–419.

    Article  CAS  PubMed  Google Scholar 

  10. Tentolouris N, Jude EB, Smirnof I, et al.: Methicillin resistant Staphylococcus aureus: an increasing problem in the diabetic foot clinic. Diabet Med 1999, 16:9:767–771.

    Article  Google Scholar 

  11. Noel GJ, Bush K, Bagchi P, et al.: A randomised, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Clin Infect Dis 2008, 46:656–658.

    Article  Google Scholar 

  12. Lipsky BA, Itani K, Norden C: Treating foot infections in diabetic patients: a randomised, multicentre, open label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin Infect Dis 2004, 38:17–24.

    Article  CAS  PubMed  Google Scholar 

  13. Bowling FL, Boulton AJ: Methicillin resistant Staphylococcus aureus a decreasing problem in the diabetic foot clinic. Int J Low Extrem Wounds 2009 (in press).

  14. Tentolouris N, Petrikkos G, Vallianou N, et al.: Prevalence of methicillin resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 2006, 12:186–189.

    Article  CAS  PubMed  Google Scholar 

  15. Dang CN, Prasad YD, Boulton AJ, et al.: Methicillin resistant Staphylococcus aureus: in the diabetic foot clinic: a worsening problem. Diabet Med 2003, 20:159–161.

    Article  CAS  PubMed  Google Scholar 

  16. Bendy RH, Nuccio E, Wolfe B, et al.: Relationship of quantitative wound bacterial count to healing decubiti. Effect of topical gentamycin. Antimicrob Agents Chemother 1964, 4:147–155.

    Google Scholar 

  17. Robson MC: Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 1997, 77:637–650.

    Article  CAS  PubMed  Google Scholar 

  18. Brook I: Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes. J Med Microbiol 1988, 27:191–198.

    Article  CAS  PubMed  Google Scholar 

  19. Kelly MJ: Wound infection: a controlled clinical and experimental demonstration of synergy between aerobic (Escherichia coli) and anaerobic (Bacteroides fragilis) bacteria. Ann R Coll Surg Engl 1980, 62:52–59.

    CAS  PubMed  Google Scholar 

  20. Kirketerp-Møller K, Jensen PØ: Distribution, organization and ecology of bacteria in chronic wounds. J Clin Microbiol 2009, 46:2717–2722.

    Article  Google Scholar 

  21. Leid JG, Shirtliff ME, Costerton JW, et al.: Human leukocytes adhere, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002, 70:6339–6345.

    Article  CAS  PubMed  Google Scholar 

  22. Fux CA, Wilson S, Stoodley P: Detachment characteristics and oxacillin resistance of Staphylococcus aureus biofilm emboli in an in vitro catheter infection model. J Bacteriol 2004, 186:4486–4491.

    Article  CAS  PubMed  Google Scholar 

  23. Lavery LA, Armstrong DG, Murdoch DP, et al.: Validation of the Infectious Disease Society of America’s Diabetic Foot Infection Classification System. Clin Infect Dis 2007, 44:562–565.

    Article  PubMed  Google Scholar 

  24. Lipsky BA: A report from the International Consensus on Diagnosing and Treating the Infected Diabetic Foot. Diabetes Metab Res Rev 2004, 20:68–77.

    Article  Google Scholar 

  25. Grundmann H, Tami A, Hori S, et al.: Nottingham Staphylococcus aureus population study: prevalence of MRSA among elderly people in the community. BMJ 2002, 321:1365–1366.

    Article  Google Scholar 

  26. Roghmann MC, Siddiqui A, Plaisance K: MRSA colonisation and the risk of MRSA bacteraemia in hospitalised patients with chronic ulcers. J Hosp Infect 2001, 47:98–103.

    Article  CAS  PubMed  Google Scholar 

  27. Tacconelli E, De Angelis G, Cataldo MA: Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008, 61:26–38.

    Article  CAS  PubMed  Google Scholar 

  28. Jeandrot A, Richard JL, Combescure C, et al.: Serum pro-calcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia 2008, 51:347–352.

    Article  CAS  PubMed  Google Scholar 

  29. Sotto A, Richard JL, Jourdan N, et al.: Miniaturized Oligonucleotide Arrays: a new tool for discriminating colonization from infection due to Staphylococcus aureus in diabetic foot ulcers. Diabetes Care 2007, 30:2051–2056.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Manchester Diabetes Centre, 193 Hathersage Road, Manchester, UK

    Frank L. Bowling

Authors
  1. Frank L. Bowling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edward B. Jude
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew J. M. Boulton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frank L. Bowling.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bowling, F.L., Jude, E.B. & Boulton, A.J.M. MRSA and diabetic foot wounds: Contaminating or infecting organisms?. Curr Diab Rep 9, 440–444 (2009). https://doi.org/10.1007/s11892-009-0072-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-009-0072-z

Keywords

Search

Navigation